InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,343.60
(
0.41%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
86.00
(
0.68%
)
Bitcoin
61,354.23
(
-0.42%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: None

Friday, 12/04/2015 1:39:01 PM

Friday, December 04, 2015 1:39:01 PM

Post# of 252412
Does anyone know the (proper) procedure for obtaining a drug to compare it to an inhouse drug or for further research? For example when a company is developing a generic do they just have a doc write a perscription despite its use not being for a patient? What if the drug has a REMS? I recall tracleer tried (is trying) to keep generics out via this route.

I became curious following this twitter thread. Is this legal?
https://twitter.com/markbaum4/status/672835449480605696
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up